You may have seen that we have recently launched our inaugural vodcast series.
Dr Astrid Nehlig, Research Director from the French National Medical Research Institute (INSERM), discusses the latest research on the relationship between coffee drinking and neurodegenerative disorders with Dr Sarah Schenker, Registered Dietitian.
In part one, which examines age-related cognitive decline and Alzheimer’s disease, Dr Astrid Nehlig, gives an overview of the latest research, which suggests that moderate coffee consumption over the course of a lifetime may help to slow down cognitive decline. When asked about Alzheimer’s disease, Dr Nehlig advises that the “research has reported that the consumption of two or three cups of coffee a day over a lifetime reduces the risk of Alzheimer’s disease by 20 to 25 per cent” though recognises that much more research and patient follow up are required.
Part two investigates coffee and Parkinson’s disease. Dr Astrid Nehlig acknowledges that there are now 30 studies, a far greater number than the research conducted on coffee and Alzheimer’s disease. “What these studies show is that regular coffee consumption decreases the risk of having Parkinson’s disease by 30% compared to non coffee drinking and what is also obvious is that every additional cup of coffee decreases this risk further”.
In both vodcasts, the different results between men and women are discussed as well as which components in coffee may be behind the observed effects. Each vodcast concludes with practical advice health professionals can give to their patients.
To view the vodcast series, click here.